Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psychosis, Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00929370
What this trial is testing

A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.

Who this might be right for
Schizophrenia
GlaxoSmithKline 34
Not applicableStudy completedNCT01619319
What this trial is testing

Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of Psychosis

Who this might be right for
Prodromal Schizophrenia
University of Calgary 32
Not applicableUnknownNCT00825045
What this trial is testing

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Centre for Addiction and Mental Health 14
Testing effectiveness (Phase 2)Study completedNCT01649557
What this trial is testing

Multicenter, Open-label, Safety and Tolerability Study

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 244
Not applicableStudy completedNCT04166019
What this trial is testing

Effect of a Peer-led Self-management Program for Recent-onset Psychosis

Who this might be right for
Early PsychosisPsychotic Disorders
Chinese University of Hong Kong 180
Testing effectiveness (Phase 2)UnknownNCT03607630
What this trial is testing

Can Imagination Change Upsetting Memories of Trauma?

Who this might be right for
Psychosis
King's College London 12
Large-scale testing (Phase 3)Study completedNCT01626872
What this trial is testing

Long-Term Study of MP-214 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 254
Post-approval studies (Phase 4)Study completedNCT02597439
What this trial is testing

Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe

Who this might be right for
Ultra High Risk for Psychosis
Rene Kahn 145
Not applicableStudy completedNCT05936983
What this trial is testing

Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia

Who this might be right for
Bipolar DisorderSchizophrenia
Yeditepe University 90
Post-approval studies (Phase 4)UnknownNCT06093451
What this trial is testing

Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder

Who this might be right for
Schizophrenia AgitationSchizo Affective DisorderBipolar Disorder+1 more
Temple University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06821945
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Boryung Pharmaceutical Co., Ltd 120
Not applicableStudy completedNCT05100875
What this trial is testing

Social Skills and Emotion Regulation Training "SSERT" for Trauma in Psychosis

Who this might be right for
PsychosisTraumaEmotion Regulation
Douglas Mental Health University Institute 19
Large-scale testing (Phase 3)Study completedNCT01720095
What this trial is testing

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

Who this might be right for
Psychosis
Nova Scotia Health Authority 22
Not applicableStudy completedNCT04352569
What this trial is testing

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia

Who this might be right for
SchizophreniaHallucinationsRefractory Schizophrenia
Centre hospitalier de Ville-Evrard, France 25
Not applicableActive Not RecruitingNCT06474195
What this trial is testing

Cue-based Intervention in Prospective Memory and Medication Adherence.

Who this might be right for
Schizophrenia
University of Pittsburgh 104
Not applicableStudy completedNCT01793324
What this trial is testing

EMR Data to Assess Monitoring of Patients Treated With Quetiapine

Who this might be right for
SchizophreniaBipolar DisorderMajor Depressive Disorder
AstraZeneca 6,153
Large-scale testing (Phase 3)Study completedNCT01129882
What this trial is testing

An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 709
Not applicableNot Yet RecruitingNCT07652866
What this trial is testing

Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia

Who this might be right for
Schizophrenia Disorder
Second Xiangya Hospital of Central South University 60
Large-scale testing (Phase 3)Ended earlyNCT00637494
What this trial is testing

Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Who this might be right for
Psychotic DepressionSevere Major Depression With Psychotic FeaturesPsychosis
Corcept Therapeutics 292
Testing effectiveness (Phase 2)Study completedNCT00314639
What this trial is testing

Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

Who this might be right for
Schizophrenia and Schizophrenia Spectrum Psychosis
Laval University 30
Next Page